Xencor | XNCR - Capitale Di Prestito





Capitale Di Prestito Cambiamento Data
AbbVie USD 58.94B 4.03B 2025-12
Alnylam Pharmaceuticals USD 2.48B 931K 2026-03
Amgen USD 51.89B 1.88B 2026-03
Arrowhead Research USD 1.23B 687.3M 2026-03
AstraZeneca USD 25.96B 177M 2026-03
Biogen USD 6.29B 1.7M 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Cytokinetics USD 247.21M 868.77M 2026-03
GlaxoSmithKline GBP 14.01B 696M 2026-03
J&J USD 37.34B 183M 2026-06
Karyopharm Therapeutics USD 278.22M 278.22M 2025-12
MacroGenics USD 68.71M 1.29M 2026-03
Merck USD 46.67B 77M 2026-03
Novartis USD 37.45B 7.86B 2026-03
Pfizer USD 60.57B 1.08B 2026-03
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Roche Holding CHF 25.22B 2.21B 2026-06
Xencor USD 82.12M 5.64M 2026-03